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Abstract
Background: Diabetes mellitus increases the rate of vaginal colonization and infection with
Candida species
Methods: We surveyed women with diabetes receiving care at either an urban or suburban
diabetes clinic to examine the relationship between vaginal Candida colonization, diabetes type and
duration, and HbA1c level. 101 participants completed the self-administered questionnaire and selfcollected a vaginal swab for Candida culture. Candida colonization was similar by age and race.
Results: Type 1 diabetics were three times as likely as type 2 diabetics to be colonized with any
Candida species (OR = 3.4; 95% CI: 1.03, 11.41; p = 0.04); even after adjusting for abnormal HbA1c,
which had an independent effect (OR = 1.4; 95% CI: 1.04, 1.76; p = 0.02). Recent antibiotic use (OR
= 4.5; 95% CI: 1.18, 16.79; p = 0.03), lifetime history of chlamydia (OR = 5.8; 95% CI: 1.09, 30.54;
p = 0.04), and performing oral sex during the past 2 weeks (OR = 4.9; 95% CI:0.84, 28.27; p = 0.08)
were also associated with Candida carriage after adjusting for diabetic type and abnormal HbA1c. C.
albicans was isolated from the majority of colonized type 1 participants (56%), while C. glabrata was
the most common isolate among colonized type 2 participants (54%).
Conclusions: Improving glucose control and possibly modifying sexual behavior may reduce risk
of Candida colonization, and potentially symptomatic infection, among women with diabetes.

Background
Diabetes mellitus predisposes individuals to bacterial and
fungal infections, including those caused by Candida species. Many investigators have suggested that vulvovaginal
candidiasis (VVC) occurs more frequently in diabetics [1–
8]. Further, chronic recurring VVC may be a marker of diabetes [9]. Several studies report increased rates of asymptomatic vaginal carriage rates of Candida species and

incidence of symptomatic infection in diabetic women,
but results are inconsistent [5,10–14]. While some show
no increase in carriage of vaginal Candida[5], those demonstrating increased Candida carriage in female diabetes
patients do not examine the effect of glucose control or diabetes type [12,14]. However, in vitro studies demonstrating impaired host response directed against Candida in
diabetics support the idea of increased rates of Candida
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colonization among diabetics [4,6,7]. Whether diabetes
leads to more symptomatic and/or more recurrent VVC
episodes is a subject of controversy.
Potential risk factors for VVC include diabetes type, severity, and degree of glucose control.[26–30] In addition to
diabetes mellitus, a number of VVC risk factors have been
identified, including African-American heritage [15–17],
previous history of VVC [15], higher education degree, intermediate age, oral contraceptive pills [3,10,16,18], use
of commercially available solutions for cleansing of external genitalia or vaginal douching, frequent sexual intercourse [17,19,10], sexual behavior (age at first intercourse,
frequency of oral-genital contact) [20], contraception devices (diaphragm, vaginal contraceptive sponge, intrauterine device), and antibiotics [3,15,19]. Whether these
factors increase risk ofCandida colonization or symptomatic infection following colonization, or both, is unknown, however, it should be emphasized that a prerequisite for symptomatic vaginitis is vaginal colonization.
Few studies have addressed the relationship between Candida colonization, VVC, and diabetes; none we are aware
of have examined the role of behavioral VVC risk factors
for colonization among persons with diabetes. To evaluate the relationship between Candida colonization and
hypothesized risk factors for vulvovaginal candidiasis colonization in diabetics, we conducted a cross-sectional
study among female diabetes patients receiving care at
one of two diabetes clinics. We describe the associations
between Candida colonization, sociodemographics,
health behaviors, diabetes type, diabetes severity, and Hemoglobin A1c level among women with type 1 and type 2
diabetes.

Methods
Study population
Female diabetes patients seen at an outpatient academic
diabetes practice of Wayne State University Division of
Endocrinology, Department of Internal Medicine, were eligible for study. The practice included an urban (University Health Center, Detroit, MI) clinic and a suburban clinic
(Hechtman Clinic, Bingham Farms, MI). Patients were diagnosed with type 1 and type 2 diabetes on clinical presentation by a board certified endocrinologist. Potential
participants were approached in the clinic waiting room
and consent obtained. As an incentive for participation,
subjects were rewarded with video rental gift certificates
(value $5). Participants consented to a medical record review which included abstraction of total glycated hemoglobin levels obtained at the enrollment visit, completed
a self-administered questionnaire and self-collected a vaginal swab. The questionnaire addressed the following variables: sociodemographic (age, race, marital status,
insurance status, highest education completed, occupa-
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tion); diabetes duration, type, severity, and abnormal glucose level; lifetime history of physician diagnosed VVC
episodes; recent antibiotic use, by type; sexual history;
health behaviors. For the diabetes section we used questions from the Diabetes Care Profile, an instrument developed and validated by the Michigan Diabetes Research
and Training Center [21,22]. The study protocol was approved by the Institutional Review Boards at the University of Michigan and Wayne State University.
Of 155 women approached, 105 (67.7%) consented. One
woman was ineligible because her vaginal sample was
lost. Two women decided to stop participating during the
study; one did not understand the questionnaire, while
the other felt the questionnaire was too intrusive, leaving
a final sample size of 101 participants.
Laboratory methods
All vaginal specimens were cultured for yeast. Specimens
were placed on plates with media selective for Candida
growth (Sabouraud's dextrose agar). Suspected mixed
samples, as determined by colony type and microscopic
characteristics, were placed on plates with media showing
species-specific colony color change (Chromagar, CHROMagar, Paris, France). C. albicans and C. glabrata were
identified by chlamydospore and germ tube tests; all other
species were identified by carbohydrate assimilation tests
(API-20C AUX).
Data analysis
We described the distributions of hypothesized variables
among participants, using simple descriptive statistics,
and the associations between hypothesized risk factors
and Candida colonization using odds ratios (OR) and
Cornfield 95% confidence intervals (CI). After a detailed
stratified analysis, to assess confounding and effect modification, we fit a logistic regression model for Candida carriage. We calculated ORS and 95% CIs for the bivariate
analyses using EpiInfo [23]; all other analyses and data
management were done using SAS [24]. Several variables
strongly associated with Candida colonization had small
numbers of missing values, particularly for oral sex (13%)
and douching (9%) (others did not exceed 5%). In this
case, for the multivariate analyses, we inferred that a missing response was equivalent to a negative response. If we
are wrong in this inference, the resulting estimates will be
biased towards the null hypothesis of no effect. Excluding
the missing responses from the relevant analyses only
modestly changed the point estimates.

Results
Demographic characteristics by clinic
Fifty-nine participants were recruited from UHC; fortytwo were recruited from Hechtman. Mean age among
UHC participants was 52.3 years, while mean age among
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Hechtman participants was 50.0 years (p = 0.5). The clinics varied greatly, however, in participant ethnicity. Forty
of fifty-nine (67.8%) UHC participants were of African
American descent. By contrast, eight of 42 (19.0%) Hechtman participants were of African American descent.
Diabetes characteristics
Most participants had type 2 diabetes (62/101 = 61%). By
clinic, type 2 was more common among UHC participants
(69%), but was equally distributed among Hechtman participants.

Total glycated hemoglobin levels measured at the time of
the enrollment visit were abstracted from patient's charts.
We assessed glycemia by transforming total glycated hemoglobin levels to hemoglobin A1c (HbA1c) values using
a linear regression formula [25]. For the Wayne State University patient population, a value of HbA1c > 6.4% is abnormal. This cutpoint was determined by standard
clinical laboratory comparison methods and verification
of the reference interval [26–30]. The mean HbA1c for our
study population was 7.91, with a range of 4.4–15.7.
Overall, only 20 of 101 participants (19.8%) had normal
HbA1c at time of enrollment. Type 1 subjects had a higher
proportion of abnormal levels (92.3%) than type 2 subjects (72.6%) (p = 0.02).
Correlates of Candida colonization
29 of 101 (28.7%) participants were colonized with Candida species. 2 of the 29 (6.9%) were colonized with two
Candida species. The most common species were C. albicans (12/29 = 41.4%) and C. glabrata (11/29 = 37.9%). C.
albicans predominated among women with type 1 (9/16
colonized or 56%) and C. glabrata among women with
Type 2 (7/13 colonized or 54%). We identified one isolate
of C. parapsilosis, C. guilliermondii, and Trichosporon beigelli.

Type 1 patients were more likely to be colonized with
Candida than type 2 patients (OR = 2.6; 95% CI: 0.99,
6.98; p = 0.03) (Table 1). Women with abnormal HbA1c
were almost three times more likely to be colonized with
Candida than those with normal HBA1c, but this association was not statistically significant (OR = 2.7; 95% CI:
0.68, 15.39; p = 0.13). No statistically significant association was detected between Candida colonization and duration of diabetes, although those who were colonized in
each diabetic type tended to have longer duration of diabetes (mean duration diabetes, colonized v. not: type 1:
15.7 v. 20.2 y, p = 0.34; type 2: 9.8 v. 16.1 y, p = 0.28). Average duration of diabetes among colonized women did
not differ by type (type 1: 20.2 v. type 2: 16.1; p = 0.53).
Age, race, marital status, education, and employment
were not significantly associated with Candida colonization (Table 1). Antibiotic use in the past 2 weeks, lifetime
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history of chlamydia, douching, and report of both performing and receiving oral sex in the last two weeks were
strongly associated with Candida colonization, whereas
vaginal-penile sex had only a modest and not statistically
significant assocation with Candida colonization. When
stratified by oral sex, there was no association between
vaginal sex and colonization status. However, the effect of
oral sex remained after stratification by vaginal sex.
Multivariate Analyses
To simultaneously adjust for variables independently associated with Candida colonization in the crude analyses,
we fit a logistic regression model predicting Candida carriage (Table 2). Because of the small sample size, we created a base model including age, diabetes type, abnormal
HbA1c, recent antibiotic use, and performing oral sex. We
assumed for this analysis that those who did not respond
to questions about oral sex did not engage in oral sex. Receiving oral sex was not associated after adjustment for
performing oral sex (OR = 1.07; 95 % CI: 0.12, 9.42, p =
0.95) and thus was excluded from the base model. Other
variables associated in the bivariate analyses were added
one at a time to the base model. After adjustment, older
age, having type 1 diabetes, an abnormal HbA1c level, and
report of antibiotic use during the previous 2 weeks were
statistically significantly associated with Candida colonization. Performing oral sex was associated with an almost
fivefold increase in colonization, but the association was
not statistically significant (p = 0.08). When added individually to the base model, lifetime history of chlamydia
(OR = 5.8; 95% CI: 10.9, 30.54) but not douching (OR =
2.2; 95 % CI: 0.68, 7.00) remained strongly associated
with colonization. Four participants positive for Candida
also had a previous chlamydia diagnosis and reported
douching. When entered simultaneously into the model,
the estimates were unstable, thus, they were entered separately. Douching and history of chlamydia were also
strongly associated with performing oral sex; adding each
of these variables reduced the parameter estimate and statistical significance of the association with performing
oral sex. Pregnancy history had no association with colonization after adjustment (OR = 0.97; 95% CI:0.26, 3.66).

Discussion
Among women with diabetes, Candida carriage increased
with older age, type 1 diabetes, abnormal HbA1c level,
oral antibiotic use in the previous two weeks, and ever history of chlamydia. Other VVC risk factors, including African American descent, lifetime history of VVC, higher
education, oral contraceptive use, and frequency of vaginal intercourse were not significantly associated with Candida colonization after adjustment for other variables.
These data suggest that behavioral factors, as well as
HbA1c, are important determinants of Candida colonization among women with diabetes.
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Table 1: Association of Candida colonization with host characteristics among 101 women with diabetes recruited from urban and suburban clinics (2000)

Characteristic

Diabetes Type
Type 1
Type 2
Hemoglobin A1c+
Normal (4–6.4%)
Abnormal (> 6.4%)
Duration (miss = 5)
< 5 years
6–14 years
> 14 years
Age
18–44
45–59
60+
Race (miss = 1)
White
Black
Asian
Marital Status (miss = 6)
Never married
Married, living with spouse
Married, not living with
spouse; and/or separated
Widowed or divorced
Education (miss = 4)
High school or less
Vocational/Associate/ Some college
Bachelor's degree and higher
Employed (miss = 8)
Not employed
Part-time
Full-time
Insurance (miss = 10)
No
Yes
Antibiotics (oral only)
None
Taken in last two weeks
Lifetime history of Chlamydia (miss = 5)
No
Yes
Douche (miss = 9)
No
Yes
Oral sex in past 2 weeks (miss = 13)
None
Perform only
Receive only
Perform and Receive
Vaginal-penile sex in past 2 weeks (miss =
8)
None
Yes

Not Colonized
Number

Colonized
Number

23
49

16
13

17
55

OR

95% CI

p-value

2.62

(0.99, 6.98)

0.03

3
26

2.68

(0.68, 15.39)

0.13

24
26
19

9
4
14

0.41
1.96

(0.08,1.74)
(0.63, 6.32)

0.17
0.20

24
21
27

7
15
7

2.45
0.89

(0.75, 8.45)
(0.23, 3.46)

0.10
0.85

38
32
1

13
15
1

1.37
2.92

(0.52, 3.64)
(0.03, 234.35)

0.48
0.44

11
30
5

6
12
2

0.73
0.73

(0.19,3.00)
(0.05, 6.55)

0.61
0.75

22

7

0.58

(0.13,2.69)

0.42

25
26
19

6
15
6

2.40
1.32

(0.72, 8.72)
(0.30, 5.78)

0.11
0.67

30
14
22

15
3
9

0.43
0.82

(0.07., 1.91)
(0.26, 2.44)

0.22
0.69

0
64

3
24

--

(0.0, 0.98)

0.02*

65
7

20
9

4.18

(1.19, 14.84)

0.01*

65
3

23
5

4.71

(0.83,32.12)

0.04*

48
17

15
12

2.26

(0.79, 6.37)

0.09

58
1
3
2

17
1
1
5

3.41
1.14
8.53

(0.04,272.31)
(0.02, 15.23)
(1.22,93.93)

0.42*
1.00*
0.02*

45
15

22
11

1.50

(0.53,4.17)

0.39

+Note: HbA calculated from a linear regression formula using total glycated hemoglobin values. Cut points based on local laboratory values. *21c
tailed Fisher's Exact Test
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Table 2: Logistic regression models predicting Candida colonization among 101 women with type 1 or type 2 diabetes (2000)

Variable Name

Parameter
Estimate

p-value

Odds Ratio

Age 45 and older
Diabetes type 1
Glycemia (% HbA1c)*
Antibiotics in past 2 weeks (oral only)
Perform oral sex in past 2 weeks
Douche
Lifetime history of chlamydia

1.92
-1.23
0.30
1.49
1.59
0.78
1.75

0.008
0.04
0.02
0.03
0.08
0.19
0.04

6.8
3.4
1.36
4.5
4.9
2.2
5.8

(95% CI)

(1.64, 28.37)
(1.03, 11.41)
(1.04,1.76)
(1.18, 16.79)
(0.84, 28.27)
(0.68, 7.00)
(1.09,30.54)

* HbA (%) > 6.4. HbA calculated from a linear regression formula using total glycated hemoglobin values. Cut points based on local laboratory
1c
1c
values. NOTE: All models included age, diabetes type, HbA1c, antibiotic use, and oral sex.

Women with type 1 diabetes had higher Candida colonization rates than those with type 2, even after adjusting for
age, behavioral factors and HbA1c. One possible explanation is difference in duration of Candida carriage: women
with type 1 and type 2 diabetes may be equally likely to
acquire Candida, but those with type 1 may be less able to
clear it. Similar to previous reports, C. albicans was isolated from the majority of colonized type 1 participants,
while C. glabrata was the most common isolate in type 2
participants, but our numbers are small [1]. Whether this
is due to diabetes type or reflects different distributions of
Candida species by age or both is uncertain.
The observation that hyperglycemia in type 1 diabetes increases risk for Candida colonization is consistent with
previous reports [1,5,6,31]. A New Zealand study of 124
women with type 1 diabetes found 7 of 7 women with elevated glycated hemoglobin reported vaginal symptoms
for the previous year, compared with 60% overall [10].
Hyperglycemia limits neutrophil function among persons
with type 1 diabetes, including neutrophils' ability to
phagocytose and kill Candida organisms. With the oxidative killing ability of neutrophils hindered, diabetics may
not be able to clear pathogens as well as non-diabetics
[1,6,7,31]. Hyperglycemic individuals may also have increased risk for Candida colonization because their secretions contain glucose, which can serve as nutrients for
Candida organisms. Sobel and colleagues reported a fucose (6-deoxy-galactose) vaginal epithelial cell receptor
that aids in adhesion of Candida to vaginal epithelial cells
[32]. Since fucose contains an isomer of glucose and acts
as one form of receptor site for Candida adhesion, it is possible that increased Candida colonization is proportional
to glucose level. Receptor avidity may be a reflection of increased glucose levels in the blood and tissues. Glycemia,
however, does not fully explain the observed increased
risk of Candida colonization.

We found a borderline significant association with performing oral sex associated with an almost five-fold increase in vaginal colonization with Candida. Receiving but
not performing oral sex has been previously reported as a
risk factor for VVC [15]. Oral sex may facilitate transmission of yeast, as Candida often colonizes the oral cavity
[15,33]. Diabetics may be more likely to carry Candida in
the oral cavity than their sex partner; thus, performing oral
sex on their sex partner prior to vaginal intercourse may
serve to inoculate the vaginal cavity. Douching has also
been previously associated with Candida colonization
[17,19,20]. The practice is hypothesized to disrupt vaginal
flora; vaginal symptoms may also lead a women to
douche so the direction of effect is unclear. The association we observed with chlamydia is probably a marker of
sexual behavior rather than a causal factor; for example,
women who reported a history of chlamydia were more
likely to douche and to report engaging in oral sex, although it is possible that chlamydia carriage adversely affects the vaginal flora increasing the chance of Candida
colonization. Recent antibiotic use is a well-described correlate of symptomatic Candida vaginitis [3,15–18,34].
While asymptomatic infection is not equivalent to disease, antibiotic use may act to alter the vaginal microenvironment to facilitate Candida colonization in the same
way it is hypothesized to promote VVC.
Women aged 45 years and older in our study were more
likely to be colonized with Candida species. We are unaware of colonization studies in women of comparable
age; most have emphasized women of childbearing age
[8,35,36]. Whether our observation is a real finding or a
reflection of our age distribution (18–84) or unknown selection biases which led to inclusion in our study requires
further investigation. However, incidence of symptomatic
infection is higher in younger (18–44) women [15].
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This study is small and was intended to be hypothesis generating. The study population is in no way representative
of all females with diabetes, although the age and racial
distribution of participants reflected that of the participating clinics. Although it is possible that women with a history of symptomatic infection might have been more
likely to participate, we have no reason to believe that
women differentially participated by both symptomatic
history and other variables under study which would have
biased our results. Further, as women were unaware of
whether they carried Candida at the time of completing
the questionnaire, it seems unlikely that a differential recall of behaviors among colonized and non-colonized
might have occurred. A final concern is that Candida colonization, while the first step toward VVC, is not equivalent
to symptomatic infection. Larger, more definitive studies,
which include a non-diabetic control group and prospective follow-up, are planned.
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Conclusions
We found strong, statistically significant associations between vaginal Candida colonization and antibiotic use,
lifetime history of chlamydia, diabetes type and HbA1c
level and a borderline significant association with performing oral sex. More non-albicans species were observed
among women with type 2 diabetes. Improving glucose
control and possibly modifying sexual behavior may reduce risk of Candida colonization, and potentially symptomatic infection, among women with diabetes.
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